Novartis Investigative Site

Hoorn 1625 HV

0 studies enrolling now · 5 studies all time

What they study most

Atherosclerosis, Atherosclerotic Cardiovascular Disease, Chronic Obstructive Pulmonary Disease, Familial Hypercholesterolemia, Heart Failure With Reduced Ejection Fraction, Secondary Progressive Multiple Sclerosis, Symptomatic Atherosclerosis, Type2 Diabetes

Studies at this site

• Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) — Completed
• An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations — Completed